ATE337020T1 - Fettsaure analoge zur diagnose von kranzarterie erkrankungen - Google Patents

Fettsaure analoge zur diagnose von kranzarterie erkrankungen

Info

Publication number
ATE337020T1
ATE337020T1 AT00922209T AT00922209T ATE337020T1 AT E337020 T1 ATE337020 T1 AT E337020T1 AT 00922209 T AT00922209 T AT 00922209T AT 00922209 T AT00922209 T AT 00922209T AT E337020 T1 ATE337020 T1 AT E337020T1
Authority
AT
Austria
Prior art keywords
crony
diagnosis
fatty acid
acid analogues
artery diseases
Prior art date
Application number
AT00922209T
Other languages
English (en)
Inventor
John W Babich
Kevin Maresca
Timothy Shoup
David R Elmaleh
Original Assignee
Molecular Insight Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Insight Pharm Inc filed Critical Molecular Insight Pharm Inc
Application granted granted Critical
Publication of ATE337020T1 publication Critical patent/ATE337020T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fats And Perfumes (AREA)
AT00922209T 1999-04-14 2000-04-14 Fettsaure analoge zur diagnose von kranzarterie erkrankungen ATE337020T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12929899P 1999-04-14 1999-04-14

Publications (1)

Publication Number Publication Date
ATE337020T1 true ATE337020T1 (de) 2006-09-15

Family

ID=22439338

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00922209T ATE337020T1 (de) 1999-04-14 2000-04-14 Fettsaure analoge zur diagnose von kranzarterie erkrankungen

Country Status (9)

Country Link
US (1) US6437103B1 (de)
EP (1) EP1173226B1 (de)
JP (1) JP2003517457A (de)
AT (1) ATE337020T1 (de)
AU (1) AU778834B2 (de)
CA (1) CA2366789C (de)
DE (1) DE60030270T2 (de)
ES (1) ES2269131T3 (de)
WO (1) WO2000061196A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69636881T2 (de) * 1995-12-01 2007-09-20 Molecular Insight Pharmaceuticals, Inc., Cambridge Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung
WO2003077727A2 (en) * 2002-03-11 2003-09-25 Biostream, Inc. Technetium-dipyridine complexes, and methods of use thereof
JP4951798B2 (ja) * 2002-04-01 2012-06-13 モレキュラ インサイト ファーマシューティカルズ インコーポレイテッド 側基脂肪酸撮像剤
WO2004093650A2 (en) * 2003-04-17 2004-11-04 The General Hospital Corporation Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid
KR100533674B1 (ko) * 2004-02-25 2005-12-06 한국원자력연구소 수소화붕소 교환수지를 이용한 레늄 착물의 제조방법
ES2380680T3 (es) * 2005-06-08 2012-05-17 Ge Healthcare Limited Procedimiento de uso de monóxido de carbono [11C] en la síntesis de marcaje interno de ésteres marcados con 11C mediante carbonilación fotoinducida de radicales libres sensitizados

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4524059A (en) 1983-01-28 1985-06-18 The General Hospital Corporation Fatty acid analogs
US4615876A (en) 1983-04-25 1986-10-07 Curators Of The University Of Missouri Macrocyclic complexes of technetium-99m for use as diagnostic radionuclides
US4746505A (en) 1985-04-26 1988-05-24 President And Fellows Of Harvard College Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands
DE69636881T2 (de) * 1995-12-01 2007-09-20 Molecular Insight Pharmaceuticals, Inc., Cambridge Stereoisomere von fettsäureanalogen zur diagnostischen bildgebung

Also Published As

Publication number Publication date
WO2000061196A2 (en) 2000-10-19
CA2366789C (en) 2010-09-28
AU4243300A (en) 2000-11-14
EP1173226B1 (de) 2006-08-23
CA2366789A1 (en) 2000-10-19
DE60030270T2 (de) 2007-08-30
AU778834B2 (en) 2004-12-23
US6437103B1 (en) 2002-08-20
EP1173226A2 (de) 2002-01-23
WO2000061196A3 (en) 2001-07-26
ES2269131T3 (es) 2007-04-01
JP2003517457A (ja) 2003-05-27
DE60030270D1 (de) 2006-10-05

Similar Documents

Publication Publication Date Title
WO2002040634A3 (en) Expression miniarrays and uses thereof
NO20021281L (no) Vaskul¶r beleggingssammensetning
ATE379990T1 (de) Verfahren zur darstellung von abgestorbenen zellen in-vivo
MX9606386A (es) Agentes que afectan la hemostasis trombotica.
EP1124598A4 (de) System zur diagnose von harninkontinenz
ID29621A (id) ASETILENIK α-AMINO ASAM HIDROKSAMAT SULFONAMIDA BERBASIS ASAM PENGHAMBAT-PENGHAMBAT TACE
ATE527552T1 (de) Mr-darstellungsverfahren zur diskriminierung zwischen gesundem und tumorgewebe
DE69010764D1 (de) Verfahren für chirurgische Implantate.
DE60029799D1 (de) Verbindungen, verfahren und pharmazeutische zubereitungen zur behandlung von zellschäden wie zum beispiel schäden an nerven- oder kerzgefässgewebe
EP1373567A4 (de) "nachweis von sequenzen, die reich an methyliertem cpg sind, zur diagnose maligner zellen"
DE60038922D1 (de) Zusammensetzungen für den wiederaufbau von knochengewebe
ATE350030T1 (de) Nordihydroguaiaretinsäurederivate zur behandlung von tumoren
DE60223176D1 (de) Metallkomplexverbindungen
WO2003010336A3 (de) Molekulare marker beim hepatozellulären karzinom
ATE375517T1 (de) Diagnosestellung von akuten myokardialen, ischämischen erkrankungen durch kombination von markern
BR0014150A (pt) Diagnósticos e terapêuticos para osteoporose
DK1178726T3 (da) Vandig opløsning til konservering af væv og organer
ATE304712T1 (de) Thrombozyten-aktivierten vollblutgerinnungszeit
DE50101479D1 (de) Fluoresceinisothiocyanat-(fitc)-sinistrin, seine herstellung und verwendung
ATE338142T1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
DE60030270D1 (de) Fettsaure analoge zur diagnose von kranzarterie erkrankungen
DE60038614D1 (de) Verfahren zur diagnose von synovialen oder osteoartikulären erkrankungen
TR200103125T2 (tr) Otizmin iyileştirilmesinde kullanıma yönelik antikonvülsan türevleri.
TR200200278T2 (tr) Kalsilitik bileşimler
DE60006144D1 (de) Verfahren für die elektrochemische herstellung von ni(0) phosphit und diphosphitkomplexen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties